ABBOTT RAPID DX NORTH AMERICA, L

Abbott Rapid DX North America LLC specializes in the manufacturing and distribution of in vitro diagnostic substances and rapid point-of-care testing systems, serving critical public health and military readiness needs. The company’s core technical expertise lies in the design, production, and supply of molecular and antigen-based diagnostic kits, including nucleic acid amplification tests and lateral flow immunoassays, such as those used for COVID-19 and strep A detection. Their capabilities extend to the integration of diagnostic platforms with clinical workflows, ensuring rapid, accurate, and deployable testing solutions in austere or high-throughput environments. Key differentiators include scalable manufacturing of FDA-authorized diagnostic products and the ability to deliver mission-critical test kits under tight operational timelines, supporting both clinical and field-based applications. The contractor maintains a dominant presence with the Department of Defense, consistently supplying rapid diagnostic tools to support force health protection, deployable medical units, and contingency operations. Additional engagement with the Department of Veterans Affairs and the Department of State reflects a broader role in sustaining diagnostic infrastructure for veteran healthcare and overseas medical missions. These relationships indicate a trusted, recurring vendor status for time-sensitive, high-volume diagnostic procurement. Primarily operating under NAICS 423450 and 325413, the company functions as both a merchant wholesaler of medical diagnostics and a manufacturer of in vitro diagnostic substances, positioning itself at the intersection of supply chain logistics and clinical diagnostics. Their vertical specialization centers on infectious disease detection, point-of-care technologies, and laboratory-grade rapid testing systems. As a 2L entity based in Orlando, Florida, Abbott Rapid DX North America LLC operates as a corporate subsidiary with no active government certifications listed. Its geographic footprint and operational focus are aligned with federal medical logistics networks, emphasizing reliability and regulatory compliance in defense and public health supply chains.